<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="70646">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02186093</url>
  </required_header>
  <id_info>
    <org_study_id>1404-057-573</org_study_id>
    <nct_id>NCT02186093</nct_id>
  </id_info>
  <brief_title>Clinical, Physiological and Prognostic Implication of Microvascular Status</brief_title>
  <official_title>Clinical, Physiological and Prognostic Implication of Index of Microcirculatory Resistance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ulsan University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Keimyung University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Inje University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Stanford University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Glasgow</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital San Carlos, Madrid</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Royal Prince Alfred Hospital, Sydney, Australia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are several physiologic parameters in evaluating cardiovascular disease. This study
      will reveal which parameter is the most proper value in predicting disease severity and risk
      factors of patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Fractional Flow Reserve (FFR), index of microcirculatory resistance (IMR), and coronary flow
      reserve (CFR) will be measured in stable angina patients before coronary intervention.

      Relationship between angiographic characteristics of patients and FFR, IMR, CFR will be
      analyzed. Comparison of risk factors and prognosis between parameters will be also analyzed.
      This study will evaluate that which parameter is correlate with disease severity and risk
      factors of patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <primary_completion_date type="Anticipated">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>Spearman correlation coefficient between FFR, IMR, CFR and angiographic severity</measure>
    <time_frame>during coronary angiography</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">1197</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Korea</arm_group_label>
    <description>patients in South of Korea</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UK</arm_group_label>
    <description>patients in England</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Spain</arm_group_label>
    <description>patients in Spain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>US</arm_group_label>
    <description>patients in USA</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with stable angina
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 18

          -  Patients with stable angina

          -  FFR, IMR, CFR were measured before coronary intervention

        Exclusion Criteria:

          -  Patients who have severe side effects or contraindication to hyperemic agents (ex.
             adenosine)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bon-Kwon Koo, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul national university hosptial</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ji-Hyun Jung, MD</last_name>
    <phone>82-10-2727-3718</phone>
    <email>jbjhyun@naver.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bon-Kwon Koo, MD, PhD</last_name>
    <phone>82-2-2072-2062</phone>
    <email>bkkoo@snu.ac.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ji-Hyun Jung, MD</last_name>
      <phone>82-10-2727-3718</phone>
      <email>jbjhyun@naver.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <lastchanged_date>July 9, 2014</lastchanged_date>
  <firstreceived_date>July 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Coronary Artery Disease</keyword>
  <keyword>Angina, Stable</keyword>
  <keyword>Fractional Flow Reserve, Myocardial</keyword>
  <keyword>Coronary Angiography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
